Efficacy and tolerability balance of oxycodone/naloxone and tapentadol in chronic low back pain with a neuropathic component: a blinded end point analysis of randomly selected routine data from 12-week prospective open-label observations

Efficacy and tolerability balance of oxycodone/naloxone and tapentadol in chronic low back pain with a neuropathic component: a blinded end point analysis of randomly selected routine data from 12-week prospective open-label observations

Michael A Ueberall,1 Gerhard H H Mueller-Schwefe2 1Institute of Neurological Sciences, Nuernberg, Germany; 2Interdisciplinary Center for Pain and Palliative Care Medicine, Goeppingen, Germany Objective: To evaluate the benefit–risk profile (BRP) of oxycodone/naloxone (OXN) and tapentadol (...

Full description

Bibliographic Details
Main Authors: Ueberall MA, Mueller-Schwefe GHH
Format: Article
Language:English
Published: Dove Medical Press 2016-11-01
Series:Journal of Pain Research
Subjects:
oxycodone/naloxone
tapentadol
chronic low back pain
neuropathic component
non-interventional study
German Pain registry
random data selection
blinded endpoint analysis
benefit-risk profile
Online Access:https://www.dovepress.com/efficacy-and-tolerability-balance-of-oxycodonenaloxone-and-tapentadol--peer-reviewed-article-JPR

Internet

https://www.dovepress.com/efficacy-and-tolerability-balance-of-oxycodonenaloxone-and-tapentadol--peer-reviewed-article-JPR

Similar Items